Honey
CAS 8028-66-8
Honey (CAS 8028-66-8) is a pharmaceutical compound with 0 bioactivity targets and 125 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Honey is linked to DTXSID90873846 in DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| HONEY | 285279 | SU | MTHSPL |
| honey | 285279 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Honey used for in pharmaceutical contexts?
Honey (CAS 8028-66-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Honey?
Honey has 125 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Acute kidney injury, Back pain, Blood uric acid increased, Burns second degree, Catheter site erythema. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Honey also used in cosmetics?
No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for Honey.
What clinical phase is Honey in?
No phase 1-4 clinical development badge is rendered for Honey because the matched compound identifier rows do not contain a max-phase value.